Glucocorticoid receptor antagonist Org34517 as a chemosensitizing agent for ovarian cancer.

e16556 Background: Anti-tumor activity has been predicted for glucocorticoid receptor antagonists (GRAs) for some solid organ malignanies. Org34517, the first selective GRA studied in humans, has s...